Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: The G-TOG non-inferiority RCT

Jonathan D.C. Ross*, Jan Harding, Lelia Duley, Alan A. Montgomery, Trish Hepburn, Wei Tan, Clare Brittain, Garry Meakin, Kirsty Sprange, Sukhwinder Thandi, Louise Jackson, Tracy Roberts, Janet Wilson, John White, Claire Dewsnap, Michelle Cole, Tessa Lawrence

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    5 Citations (SciVal)
    Original languageEnglish
    Pages (from-to)1-103
    Number of pages103
    JournalHealth Technology Assessment
    Volume23
    Issue number20
    DOIs
    Publication statusPublished (VoR) - 17 May 2019

    Funding

    The research reported in this issue of the journal was funded by the HTA programme as project number 12/127/10. The contractual start date was in July 2014. The draft report began editorial review in August 2017 and was accepted for publication in October 2017. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors’ report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report. This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health and Social Care. If there are verbatim quotations included in this publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health and Social Care. Funding: This project was funded by the National Institute for Health Research Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 20. See the NIHR Journals Library website for further project information.

    Fingerprint

    Dive into the research topics of 'Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: The G-TOG non-inferiority RCT'. Together they form a unique fingerprint.

    Cite this